Kim Y J, Rosenberg L E
Proc Natl Acad Sci U S A. 1974 Dec;71(12):4821-5. doi: 10.1073/pnas.71.12.4821.
Cystathionine beta-synthase [L-serine hydrolyase (adding homocysteine), EC 4.2.1.22] was studied in cultured skin fibroblasts from two control subjects and three patients with pyridoxine-responsive homocystinuria. In crude cell sonicates, cystathionine synthase activity detected in each mutant line was less than 5% of control values. After differential centrifugation, ammonium sulfate fractionation, and calcium phosphate gel treatment, the specific activity of synthase from control lines increased 5- to 7-fold with 70-79% yield. These same steps led to only 2- to 3-fold purification of mutant synthase and a reduced yield (26-44%). Michaelis-Menten analyses with the partially purified enzyme revealed that each mutant synthase had a marked reduction in affinity for its coenzyme, pyridoxal 5'-phosphate, as well as reduced affinity and maximum velocity for both co-substrates, L-homocysteine and L-serine. Even at saturating concentrations of coenzyme, mutant synthase activity was less than 3% of control. Mutant synthase was also far more thermolabile than control enzyme. In the absence of added coenzyme, heating for 10 min at 55 degrees led to complete loss of mutant activity whereas control activity was reduced by 60%. Significantly, addition of saturating concentration of coenzyme prior to heating increased thermostability of both control and mutant synthase, the fractional increase being considerably greater in the mutants. We conclude that these patients suffer from a mutation of the synthase apoenzyme which impairs coenzyme binding, and that this primary abnormality results in reduced total enzyme activity in two ways: by reducing holoenzyme formation; and by accelerating apoenzyme degradation. We propose that pharmacologic amounts of pyridoxine increase holoenzyme formation modestly, thereby enhancing catalytic activity and slowing apoenzyme turnover.
在来自两名对照受试者和三名吡哆醇反应性同型胱氨酸尿症患者的培养皮肤成纤维细胞中,对胱硫醚β-合酶[L-丝氨酸水解酶(添加高半胱氨酸),EC 4.2.1.22]进行了研究。在粗细胞超声裂解物中,每个突变株系中检测到的胱硫醚合酶活性低于对照值的5%。经过差速离心、硫酸铵分级分离和磷酸钙凝胶处理后,对照株系合酶的比活性提高了5至7倍,产率为70 - 79%。相同步骤仅使突变合酶纯化了2至3倍,且产率降低(26 - 44%)。对部分纯化的酶进行米氏分析表明,每个突变合酶对其辅酶磷酸吡哆醛的亲和力显著降低,对两种共底物L-高半胱氨酸和L-丝氨酸的亲和力及最大反应速度也降低。即使在辅酶饱和浓度下,突变合酶活性也低于对照的3%。突变合酶也比对照酶对热更不稳定。在不添加辅酶的情况下,55℃加热10分钟导致突变活性完全丧失,而对照活性降低60%。值得注意的是,加热前添加饱和浓度的辅酶可提高对照和突变合酶的热稳定性,突变体中的增加幅度更大。我们得出结论,这些患者患有合酶脱辅基酶的突变,该突变损害了辅酶结合,并且这种原发性异常通过两种方式导致总酶活性降低:通过减少全酶形成;以及通过加速脱辅基酶降解。我们提出,药理剂量的吡哆醇适度增加全酶形成,从而增强催化活性并减缓脱辅基酶周转。